Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/mark-allen-group/correction-and-management-of-dermal-filler-misplacement-post-lip-Wx0BBSLW13
References (22)
-
D. Back, M. Orme (1990)
Pharmacokinetic Drug Interactions with Oral ContraceptivesClinical Pharmacokinetics, 18
-
K. Meyer, E. Chaffee, G. Hobby, M. Dawson (1941)
HYALURONIDASES OF BACTERIAL AND ANIMAL ORIGINThe Journal of Experimental Medicine, 73
-
M. Venkataram (2012)
ACS(I) Textbook on Cutaneous and Aesthetic Surgery -
R. Jeevan, J. Birch, Anthony Armstrong (2011)
Travelling abroad for aesthetic surgery: Informing healthcare practitioners and providers while improving patient safety.Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 64 2
-
R. Sutherland, E. Croydon, G. Rolinson (1970)
Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and DicloxacillinBritish Medical Journal, 4
-
F. Stevenson, K. Cox, N. Britten, Y. Dundar (2004)
A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordanceHealth Expectations, 7
-
Andre Pierre, P. Levy (2007)
Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrectionJournal of Cosmetic Dermatology, 6
-
P. Guise (2012)
Sub-Tenon’s anesthesia: an updateLocal and regional anesthesia, 5
-
C. Banks (2002)
Taking the hot seat.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 16 47
-
C. Picton, T. Granby (2002)
Maintaining and developing competencies in nurse prescribing.British journal of community nursing, 7 2
-
J. Brackenbury (2014)
Managing dermal filler complications part 1: the Tyndall effect phenomenonJournal of Aesthetic Nursing, 3
-
R. Sherman (2009)
Avoiding dermal filler complicationsClinics in Dermatology, 27
-
R. Hirsch, Joel Cohen, J. Carruthers (2007)
Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 33 3
-
B. Rzany, P. Becker-Wegerich, F. Bachmann, R. Erdmann, U. Wollina (2009)
Hyaluronidase in the correction of hyaluronic acid‐based fillers: a review and a recommendation for useJournal of Cosmetic Dermatology, 8
-
G. Pankey, L. Sabath (2004)
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38 6
-
A. Sclafani, S. Fagien (2009)
Treatment of Injectable Soft Tissue Filler ComplicationsDermatologic Surgery, 35
-
N. Costa (2014)
Using hyaluronidase medication to correct adverse events post soft tissue augmentationJournal of Aesthetic Nursing, 3
-
R. Stern, M. Jedrzejas (2006)
Hyaluronidases: their genomics, structures, and mechanisms of action.Chemical reviews, 106 3
-
M. Fatahzadeh, R. Schwartz (2007)
Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.Journal of the American Academy of Dermatology, 57 5
-
D. Dobie, J. Gray (2004)
Fusidic acid resistance in Staphylococcus aureusArchives of Disease in Childhood, 89
-
H. Collier (2014)
Hyaluronidase medication: why aesthetic nurses should be guided by the expertsJournal of Aesthetic Nursing, 3
-
J. Leyden, A. Kligman (1977)
The case for steroid—antibiotic combinationsBritish Journal of Dermatology, 96
- Publisher
- Mark Allen Group
- Copyright
- Copyright © 2014 MA Healthcare Limited
- ISSN
- 2050-3717
- eISSN
- 2052-2878
- DOI
- 10.12968/joan.2014.3.6.286
- Publisher site
- See Article on Publisher Site
Abstract
This paper outlines a case study of a 30-year-old woman who presented to the author, an aesthetic nurse consultant, with concerns about her lip after having a dermal filler injected a few weeks before. During her consultation, it was discovered that she was initially seen by another aesthetic nurse practitioner in the US, who injected a hyaluronic acid (HA) based dermal filler for the purpose of lip volume augmentation. This case study will reflect on how the patient was assessed and treated, considering accountability, legal and ethical issues, as well as concordance with the medical advice given to the patient. The author will also discuss diagnosis and differential diagnosis, and describe the best available treatment options that were sought to resolve the patient's condition.
Journal
Journal of Aesthetic Nursing – Mark Allen Group
Published: Jul 2, 2014